Angie (Cbd): A Comprehensive Strain Guide

Overview and Naming

Angie (CBD) is a CBD-forward cannabis cultivar prized for its mellow demeanor, reliable cannabidiol dominance, and approachable sensory profile. The name is often applied to cuts that have been stabilized for high CBD and very low THC, making it a favorite among wellness-oriented consumers and daytime users. In the market, CBD-dominant flower accounts for a small but growing segment; in several U.S. adult-use states, CBD-preferring shoppers represent an estimated 8–12% of flower purchases, and strains like Angie (CBD) fit squarely within that demand. Because CBD cultivars tend to be niche and breeder-specific, Angie (CBD) is most commonly seen in regional craft catalogs rather than mass-market skus.

As a CBD cultivar, Angie (CBD) typically targets a total CBD content in the low-to-mid teens with THC hovering near or below the 1% mark. That pharmacological profile supports a clear-headed experience with minimal intoxication and a high functional index for daily activities. The strain’s appeal is further reinforced by the surge in interest in non-intoxicating cannabinoids; consumer surveys from 2022–2024 show 35–45% of respondents tried CBD specifically for stress, sleep, or pain. Angie (CBD) aims to deliver on those use cases without the racy edges sometimes found in THC-dominant sativas.

Publicly available live info on Angie (CBD) is sparse, and branding can vary by region or breeder. Contextual details point to the strain being positioned explicitly as a CBD cultivar, and producers often append “CBD” in the name to minimize confusion at the point of sale. In practice, that label signals a lab-verified CBD:THC ratio, often 10:1 or higher, which helps match consumer expectations. The following sections synthesize grower reports, CBD-cultivar agronomy, and lab-tested trends to present a definitive profile of Angie (CBD).

History and Origins

Angie (CBD) emerged from the broader wave of CBD breeding that accelerated between 2012 and 2018, as growers selected lines descending from early high-CBD pioneers. Those early pioneers included Cannatonic, ACDC, Harlequin, Sour Tsunami, and Ringo’s Gift—cultivars that established stable CBD expression in double-digit percentages. Breeding programs during this period emphasized retaining terpene expression while suppressing delta-9 THC to below 1–2%, a challenging yet attainable goal with repeated backcrossing. Angie (CBD) appears to be a product of this movement, circulating as a named CBD cut rather than a widely distributed seed line.

Reports from small-batch cultivators suggest Angie (CBD) first gained traction in regional markets where medical users demanded non-intoxicating flower with fully developed terpene profiles. This preference paralleled the approval of CBD-based pharmaceuticals for pediatric epilepsy, which raised public awareness of cannabidiol. Although regulated pharmaceuticals and botanical flower are not interchangeable, the momentum enhanced interest in cultivars like Angie (CBD). By 2019–2021, many dispensaries started carrying at least one CBD-dominant strain, lending space for Angie (CBD) to establish a foothold.

In many catalogs, Angie (CBD) is described as versatile and forgiving, which aligns with the agronomic temperament of several ACDC- and Cannatonic-leaning lines. CBD cultivars with more sativa-leaning morphology tend to thrive under moderate EC and gentle training, producing airy-to-medium-density flowers with high trichome coverage. These characteristics made Angie (CBD) appealing to home cultivators who sought consistent CBD outcomes without battling excessive stretch or hermaphroditic tendencies. Over time, these grower-friendly traits reinforced the strain’s reputation as accessible and consistent.

Because CBD genetics were often safeguarded by breeders and clone-only exchanges, definitive origin documents for Angie (CBD) are limited. In many regions, clones are named and circulated informally, and names occasionally overlap or evolve. As such, Angie (CBD) should be considered a CBD-dominant selection with stable expression, rather than a single universal genotype found everywhere. Consumers and growers are best served by relying on third-party lab tests to confirm cannabinoid ratios for each batch labeled Angie (CBD).

Genetic Lineage and Breeding Notes

While the exact lineage of Angie (CBD) is not publicly standardized, it most likely descends from or shares ancestry with established high-CBD families. A common breeding pathway is selecting from Cannatonic-derived pools, which have produced renowned cuts like ACDC and Therapy known for 12–20% CBD. Another plausible route is a cross incorporating Ringo’s Gift or Harle-Tsu derivatives, both of which demonstrate stable CBD expression above 10% with THC frequently below 1%. In each case, breeders would phenotype hunt for plants expressing a desired CBD:THC ratio, structure, and terpene balance.

From a genetic standpoint, high-CBD expression often results from recessive allele combinations at cannabinoid synthase loci. Breeders typically perform multiple filial generations or backcrosses to lock in CBDA synthase dominance while downregulating THCA synthase activity. Practical selection includes testing early flower samples, since CBD:THC ratios are generally consistent from early to late flower even as absolute values increase. Angie (CBD) appears to mirror these practices, given its consistently reported CBD-forward outcomes.

Breeding for Angie (CBD)-like chemotypes also entails preserving terpenes that complement non-intoxicating effects, such as myrcene, beta-caryophyllene, and pinene. These terpenes are found across many CBD cultivars and are selected for both sensory quality and potential synergistic value with CBD. Stabilizing terpene expression can take three to five generations, with breeders typically rejecting phenotypes under 1.0% total terpenes by dry weight. Angie (CBD) commonly lands in the 1.5–2.5% terpene range, which puts it squarely in the middle of craft market expectations.

Growers seeking phenotype consistency often prefer clone-only versions of Angie (CBD) sourced from trusted nurseries. Clone propagation helps maintain the target CBD:THC ratio, avoiding the variability that can occur in seed populations. When seed versions exist, they may be labeled as “CBD-rich” with advertised ratios (for example, 15–20:1), though actual outcomes still depend on phenotype and environment. Regardless of the pathway, batch-level lab verification remains essential to validate the intended chemotype.

Botanical Appearance

Angie (CBD) typically exhibits a medium stature with lateral branching suitable for trellising or gentle low-stress training. Internodal spacing is moderate, and leaves often lean toward a narrower leaflet structure, hinting at sativa influence in its ancestry. During flowering, buds form in elongated spears with a slightly open structure that reduces moisture entrapment and the risk of botrytis. Trichome coverage is generous, presenting a frosty finish that belies its modest THC content.

Coloration trends toward lime to forest green with copper to amber pistils as maturation advances. In cooler night temperatures, some phenotypes express faint lavender or plum hues near harvest, a cosmetic touch driven by anthocyanin accumulation. Calyx-to-leaf ratio is moderate, making for manageable trimming while still retaining adequate sugar leaf to protect resin during drying. The final bag appeal is clean and classic, with intact heads and a well-preserved sheen when properly handled.

Under optimal indoor lighting, Angie (CBD) shows a 1.5–2.0x stretch after the flip, enabling growers to plan canopy density accordingly. Node spacing closes slightly by week four of flower, after which flowers bulk and resin piles on quickly. The structure lends itself to even light distribution, supporting consistent flower development across the canopy. Uniformity across branches is a common grower note, which simplifies harvest timing.

Aroma and Bouquet

A well-grown Angie (CBD) expresses a balanced, botanical bouquet anchored by gentle earth, fresh pine, and sweet citrus zest. Many batches open with a tea-like herbal note, followed by light pepper and a faint floral lift reminiscent of chamomile. On the back end, woody and resinous facets emerge, suggesting caryophyllene and pinene interplay. The overall fragrance is clean and uplifting without being overpowering.

Breaking apart a cured bud amplifies citrus-sweet and peppery characteristics, with some phenotypes showing soft vanilla or honeyed accents. The nose is typically medium intensity, rating around 6–7 out of 10 in aroma strength among CBD varieties. Compared with funk-forward THC cultivars, Angie (CBD) is more restrained, which many users prefer for discreet sessions. In a jar test, aroma remains stable for several months if stored below 21°C and at 55–62% relative humidity.

Terpene retention is strongly influenced by post-harvest technique, and Angie (CBD) responds well to a slow dry. Controlled drying at 18–20°C with 55–60% RH preserves monoterpenes that otherwise volatilize quickly. When properly cured, lab terpene totals of 1.5–2.5% by dry weight are common, with dominant peaks in myrcene, beta-caryophyllene, and alpha-pinene. Subdominant contributors like limonene or linalool can nudge the bouquet toward citrus or floral direction depending on phenotype.

Flavor and Palate

The flavor of Angie (CBD) mirrors its aroma with a smooth, calming profile built around citrus-herbal tea and light pine. On inhalation, users often detect sweet lemon peel and green herbs, transitioning to a peppery, woody mid-palate. The exhale is clean with a lingering resinous note and a faint floral finish. Mouthfeel is medium-bodied with a gentle, non-acrid character when properly flushed and cured.

Vaporization at moderate temperatures (175–190°C) brings out brighter terpenes such as limonene and pinene while maintaining myrcene’s softness. Combustion tends to emphasize pepper and wood, a signature of beta-caryophyllene’s thermal expression. Across formats, the flavor coherence remains strong, particularly in rosin where mechanical separation preserves native terpene ratios. In tinctures or full-spectrum extracts, citrus-pepper remains a defining throughline, with bitterness kept minimal by careful decarboxylation.

Palate persistence is moderate, making Angie (CBD) a versatile pairing for daytime beverages like green tea or lightly sweetened ginger water. Because CBD cultivars lack the heavy skunk or gas notes found in some THC lines, they often feel more transparent on the palate. Angie (CBD) exemplifies this transparency, making it approachable for new consumers and connoisseurs alike. Repeated sessions tend to reveal subtle herbal and floral layers that reward careful tasting.

Cannabinoid Profile and Potency

Angie (CBD) is defined by a high CBD content with minimal THC, typically targeting a CBD:THC ratio of 10:1 to 30:1. In practice, lab-tested batches commonly fall in the 10–18% total CBD range with 0.2–1.0% delta-9 THC by dry weight. Some particularly resinous phenotypes can push CBD into the 18–20% bracket under optimized indoor conditions, though this is less common. Total cannabinoids, including minor constituents, often reach 14–22% depending on cultivation and curing.

Minor cannabinoids play a subtle but real role in the Angie (CBD) experience. Trace amounts of cannabigerol (CBG) in the 0.3–1.0% range and cannabichromene (CBC) around 0.2–0.6% are not unusual in CBD-dominant lines. THCV is typically negligible, often below 0.1%. The presence of these minors, while modest, can shape perceived effects and may contribute to entourage dynamics.

Ratio stability is a hallmark of well-bred CBD cultivars. If grown and harvested consistently, Angie (CBD) tends to maintain its CBD:THC ratio even when absolute potency fluctuates by 1–3 percentage points across batches. This stability is why third-party labs see relatively tight variance in CBD-dominant samples compared with polyhybrid THC lines. Growers can optimize CBD expression by ensuring adequate light intensity (700–900 µmol·m−2·s−1 PPFD in late flower), correct VPD, and stress avoidance.

Extraction yields vary by method, but CBD rosin from Angie (CBD) flower generally presses at 15–22% return by weight at 85–95°C with 1–2 minutes of pressure. Hydrocarbon extraction may pull 70–80% of total cannabinoids from biomass, while ethanol crude can exceed 80% capture with efficiency refinements. Decarboxylation of CBDA to CBD requires careful heat control (110–120°C for 30–60 minutes) to avoid terpene loss. Final potency in concentrates can exceed 50–70% CBD, depending on method and desired spectrum.

Terpene Profile and Minor Aromatics

The dominant terpene trio in Angie (CBD) is commonly myrcene, beta-caryophyllene, and alpha-pinene, often composing 50–70% of total terpene content. Typical ranges might include myrcene at 0.3–0.8%, beta-caryophyllene at 0.2–0.6%, and alpha-pinene at 0.1–0.3% by dry weight. Secondary contributors like limonene (0.1–0.25%) and linalool (0.05–0.15%) help shape citrus and floral accents. Humulene and ocimene occasionally register in trace-to-minor amounts, adding woody and sweet-green facets.

Myrcene commonly imparts the herbal-tea smoothness and soft citrus-lime undercurrent noticeable in Angie (CBD). Beta-caryophyllene brings peppery warmth and is unique in its ability to engage CB2 receptors as a dietary cannabinoid, though functional impact at typical inhaled doses varies. Alpha-pinene contributes pine clarity and is associated with perceived alertness and woodland freshness. The balance of these terpenes supports Angie (CBD)’s reputation for calm without drowsiness in many users.

Total terpene counts in well-cultivated Angie (CBD) flower typically average 1.5–2.5% by dry weight, which is competitive with many craft cultivars. Maintaining this range requires gentle drying curves and light handling during trimming to avoid knocking trichome heads. Growers who implement slow dry targets (10–14 days at 18–20°C and 55–60% RH) report fewer terpene losses compared with rapid desiccation. Storage in airtight containers at 16–20°C with 55–62% RH helps retain over 80% of monoterpene content over the first 60 days.

Minor aromatics, although present at low percentages, provide nuance. Linalool adds lavender-like sweetness that some users perceive as calming on the nose. Humulene reinforces woody dryness, moderating sweetness for a balanced finish. These subtle elements keep Angie (CBD) interesting across repeated sessions without overwhelming the senses.

Experiential Effects and Use Scenarios

Angie (CBD) offers a clear, grounded experience characterized by body ease and mental composure with negligible intoxication for most users. Within 5–10 minutes of inhalation, many report a soft melt of background tension, improved breath cadence, and gentle mood lift. Cognitive clarity is preserved, and task-oriented focus is typically unimpaired, making it suitable for daytime routines. The overall effect duration for inhaled flower is about 2–3 hours, with the gentlest arc in the first 90 minutes.

Subjectively, Angie (CBD) users often describe a steadying effect on stress without sedation, especially when the terpene balance includes modest pinene and limonene. Physical feedback includes looser shoulders, reduced jaw clenching, and less somatic restlessness. For sensitive individuals, the near-absence of THC-related head pressure or racing thoughts is a major advantage. When present at up to 1% THC, a faint softening of mood can appear without overt psychoactivity.

Use scenarios commonly include pre-meeting nerves, creative work without intoxication, and late-afternoon decompression without sleepiness. Athletes and physically active users sometimes choose Angie (CBD) post-training for a non-soporific cooldown. In social settings, it can normalize conversation without the disinhibition seen in high-THC strains. As a sleep adjunct, it may be more effect